Skip to Main Content

Paper Details

CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma.
Mol Cancer Ther
26
2019
CCN, CCN1, CCN1regulates, CTGF, CYR61, DR, Gemcitabine, PDAC, PDAC cells, Pancreatic Ductal Adenocarcinoma, Pancreatic ductal adenocarcinoma, connective tissue growth factor, dCK, deoxycytidine, deoxycytidine kinase, gemcitabine, gemcitabine-resistant PDAC cells, gemcitabine-sensitive neoplastic cells, metabolic malfunctions, neoplastic, nontransformed pancreatic cells, pancreatic cancer, pancreatic cancer cells, tumor, xenograft model
Author NameAffiliation
Gargi MaityCancer Research Unit, VA Medical Center
Gargi MaityUniversity of Kansas Medical Center
Arnab GhoshCancer Research Unit, VA Medical Center
Arnab GhoshUniversity of Kansas Medical Center
Vijayalaxmi GuptaCancer Research Unit, VA Medical Center
Vijayalaxmi GuptaUniversity of Kansas Medical Center
Inamul HaqueCancer Research Unit, VA Medical Center
Inamul HaqueUniversity of Kansas Medical Center
Sandipto SarkarCancer Research Unit, VA Medical Center
Sandipto SarkarUniversity of Kansas Medical Center
Sumedha GunewardenaUniversity of Kansas Medical Center
Daniel D Von HoffThe Translational Genomics Research Institute (TGen)
Suman KambhampatiCancer Research Unit, VA Medical Center
Suman KambhampatiThe Sarah Cannon Cancer Center at HCA Midwest Health
Sushanta K BanerjeeCancer Research Unit, VA Medical Center
Sushanta K BanerjeeUniversity of Kansas Medical Center
Snigdha BanerjeeCancer Research Unit, VA Medical Center
Snigdha BanerjeeUniversity of Kansas Medical Center
  • 1 - 18

Datasets

Release 1.2